PLSI - Phoenix Life Sciences International Limited

Other OTC - Other OTC Delayed Price. Currency in USD
11.00
+2.00 (+22.22%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close9.00
Open9.05
Bid0.00 x 0
Ask0.00 x 0
Day's Range9.05 - 11.00
52 Week Range6.00 - 48.25
Volume1,635
Avg. Volume315
Market Cap336.049M
Beta (3Y Monthly)12.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    Former Assistant U.S. Attorney Joins Phoenix Life Sciences International as Company’s Vice President of Regulatory Affairs

    DENVER, CO, Feb. 01, 2019 -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions.

  • ACCESSWIRElast month

    Phoenix Life Sciences International Featured in the Cannabis Investor Magazine

    ATLANTA, GA / ACCESSWIRE / January 16, 2019 / CannaInvestor Magazine announced today Phoenix Life Sciences International Limited (OTC PINK: PLSI) (''Phoenix Life''), an international adaptive healthcare ...

  • GlobeNewswirelast month

    Phoenix Life Sciences International Announces 2019 International Expansion Strategy

    DENVER, CO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”, or the “Company”), an international adaptive healthcare solutions company, today announced its 2019 strategy for continued international expansion to its shareholders. Today, I am happy to share with you the Phoenix Life strategy for expansion in 2019. The first step the company is making to further its mission is the establishment of offices and infrastructure in the Oceania region including Australia and the Republic of Vanuatu.  Further, this will include the recruitment of an expanded team of medical, clinical trial, agricultural and pharmaceutical personnel.

  • GlobeNewswire2 months ago

    Phoenix Life Sciences International Announces Doctor Mohyuddin Mirza as Company's New Botany Specialist

    DENVER, CO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Mohyuddin Mirza has joined the company as the Botany Specialist. Dr. Mohyuddin Mirza has over three decades of experience in the management of greenhouse crops from farm to consumers including Echinacea, Rhodeola, and Cannabis and has made a significant economical impact on the botanical products industries in Alberta, Canada. “As Phoenix Life Sciences International moves forward with company expansion in the new year, we are proud to recruit the most well-respected specialists in the growing industry, like Mohyuddin Mirza,” said Phoenix Life Sciences International CEO Martin Tindall.

  • GlobeNewswire2 months ago

    Phoenix Life Sciences International Is Now Accepting Bids for Hemp CBD Producers and Manufacturers

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it is now accepting bids from U.S. licensed producers of industrial hemp to supply various products to be used in the formulation of its botanical pharmaceuticals. “As we move forward with our mission of transforming the future of global healthcare, our next step is partnering with a GMP licensed hemp producers in the U.S. that shares our values and mission to push botanical pharmaceuticals forward throughout the world,” said Phoenix Life CEO Martin Tindall. Phoenix Life is seeking a Good Manufacturing Practice (GMP) licensed industrial hemp partner for both U.S. and foreign markets to commence in January 2019.

  • GlobeNewswire2 months ago

    Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has released an online version of its Investor Relations deck with an accompanying video presentation on its website and at http://phxlife.net/PLSI-Deck. During the presentation video, Phoenix Life CEO Martin Tindall walks prospective investors through the company’s background, overall mission, business model, future plans and information on how to invest in Phoenix Life’s goal of transforming the future of global healthcare. “We are excited to release our Investor Relations deck and video presentation on our company website to provide investors in the public markets with a clear understanding of the business of Phoenix Life, our mission and our objectives,” said Phoenix Life Sciences International CEO Martin Tindall.

  • GlobeNewswire3 months ago

    Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor

    Phoenix Life Sciences International Limited (PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus Stewart has joined the company as the Agriculture and Horticulture Senior Advisor. Angus Stewart has over two decades of experience specializing in horticulture and is currently an Agricultural and Horticultural Scientist and Consultant Plant Breeder of approximately 100 commercially released plant cultivars. Additionally, Stewart has extensive experience with plant breeding techniques of all levels and is well versed in the best practices for the production and extraction of botanical active ingredients like cannabinoids.